LACK OF VESICANT INJURY FOLLOWING EXTRAVASATION OF LIPOSOMAL DOXORUBICIN

被引：45
作者：
MADHAVAN, S [1 ]
NORTHFELT, DW [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,DIV HEMATOL ONCOL,AIDS ONCOL PRACTICE,SAN FRANCISCO,CA 94143
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1995年 / 87卷 / 20期
关键词：
D O I：
10.1093/jnci/87.20.1556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1556 / 1557
页数：2
相关论文
共 11 条
  • [1] SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION
    ALLEN, TM
    HANSEN, CB
    GUO, LSS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) : 9 - 16
  • [2] Boyle D M, 1995, Oncol Nurs Forum, V22, P57
  • [3] COHEN MH, 1979, CANCER TREAT REP, V63, P1003
  • [4] DORR RT, 1989, CANCER, V64, P2462, DOI 10.1002/1097-0142(19891215)64:12<2462::AID-CNCR2820641211>3.0.CO
  • [5] 2-9
  • [6] DORR RT, 1994, CANCER CHEMOTHERAPY, P397
  • [7] TREATMENT METHODS FOR EXTRAVASATIONS OF CHEMOTHERAPEUTIC-AGENTS - A COMPARATIVE-STUDY
    LOTH, TS
    EVERSMANN, WW
    [J]. JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1986, 11A (03): : 388 - 396
  • [8] RUDOLPH R, 1976, CANCER, V38, P1087, DOI 10.1002/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO
  • [9] 2-X
  • [10] RUDOLPH R, 1979, CANCER TREAT REP, V63, P529
12